Ms Burley revealed that a poll this morning stated that 25 percent of the UK population may decide not to take a coronavirus vaccine. The Education Secretary admitted that the effectiveness of a COVID-19 vaccine is contingent on a very high proportion of the population taking it.
The Sky News host said: “A poll this morning said 25 percent of the population may refuse this vaccine.
“If they do then the effects will certainly be negative, won’t they?”
Mr Williamson replied: “Well what we have seen is the British population is very good at recognising the importance of vaccines.
“I think both you and I will have had the experience of being vaccinated, our children will have been vaccinated.
Gavin Williamson is the Education Secretary
Kay Burley quizzed the Conservative MP
“It is contingent on a very high proportion of the population taking these vaccines in order to be able to create the immunity across the whole of society.
“So it is a responsibility that I am sure the British people will recognise because it is for their safety, it is for their good and the good of the wider society as well.”
Earlier this month Matt Hancock confirmed that the UK will not join the European Union’s vaccine programme.
The Health Secretary told TimesRadio‘s Cathy Newman that the UK has got a very sophisticated domestic programme for developing the vaccine including two of the most developed candidates in the world.
Mr Hancock highlighted the Oxford vaccine as being widely recognised as the most advanced vaccine in the world.
Ms Newman asked: “Is the EU opting out of that EU scheme on vaccine purchase and if so why?”
Mr Hancock said: “That is right we have chosen not to join the EU scheme on vaccine purchase.
UK population could receive COVID-19 vaccination in time for CHRISTMAS [INSIGHT]
Coronavirus forecast: Second wave expected to hit in autumn [INSIGHT]
BBC slammed over ‘inaccurate’ coronavirus death figures by Tory MP [VIDEO]
Matt Hancock has been the Health Secretary since 2018
“The reason is it would not have allowed us to have a say in the vaccines that were procured, the price, the quantity or the delivery schedule.
“We have got a very sophisticated domestic programme, a UK programme for developing the vaccine for two of the most developed candidates in the world including the one that is widely recognised as the most advanced, the Oxford vaccine.
“We have also been putting in place contracts with other vaccine developers globally to make sure that if another vaccine from around the world comes off or can add to the programme then we will have access to that.
“Rather than disrupt that programme by joining the EU programme where we wouldn’t have any say in those matters we are carrying on with our own.”